British Airways Pensions Investment Management Ltd purchased a new stake in shares of Thermo Fisher Scientific Inc (NYSE:TMO) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 198,953 shares of the medical research company’s stock, valued at approximately $34,691,000. British Airways Pensions Investment Management Ltd owned approximately 0.05% of Thermo Fisher Scientific as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also modified their holdings of the stock. Vanguard Group Inc. boosted its position in shares of Thermo Fisher Scientific by 2.7% in the first quarter. Vanguard Group Inc. now owns 25,971,301 shares of the medical research company’s stock valued at $3,989,193,000 after acquiring an additional 695,079 shares during the period. BlackRock Inc. raised its position in shares of Thermo Fisher Scientific by 2,692.1% during the first quarter. BlackRock Inc. now owns 22,988,885 shares of the medical research company’s stock valued at $3,531,095,000 after buying an additional 22,165,530 shares during the last quarter. State Street Corp lifted its stake in shares of Thermo Fisher Scientific by 1.0% in the first quarter. State Street Corp now owns 16,085,954 shares of the medical research company’s stock valued at $2,470,802,000 after buying an additional 164,367 shares during the period. Wellington Management Group LLP increased its stake in Thermo Fisher Scientific by 5.6% during the first quarter. Wellington Management Group LLP now owns 7,512,152 shares of the medical research company’s stock valued at $1,153,867,000 after acquiring an additional 398,622 shares during the period. Finally, Morgan Stanley lifted its position in shares of Thermo Fisher Scientific by 7.6% in the 1st quarter. Morgan Stanley now owns 4,664,882 shares of the medical research company’s stock worth $716,526,000 after acquiring an additional 327,826 shares during the period. 83.36% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: This report was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this report on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The original version of this report can be read at https://www.dispatchtribunal.com/2017/10/01/198953-shares-in-thermo-fisher-scientific-inc-tmo-acquired-by-british-airways-pensions-investment-management-ltd.html.
In other news, SVP Gregory J. Herrema sold 30,000 shares of the firm’s stock in a transaction dated Wednesday, August 2nd. The shares were sold at an average price of $176.02, for a total value of $5,280,600.00. Following the completion of the sale, the senior vice president now owns 67,016 shares in the company, valued at approximately $11,796,156.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Peter E. Hornstra sold 3,894 shares of the business’s stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $185.18, for a total value of $721,090.92. Following the transaction, the vice president now owns 19,751 shares of the company’s stock, valued at approximately $3,657,490.18. The disclosure for this sale can be found here. Insiders have sold a total of 52,738 shares of company stock valued at $9,302,112 over the last quarter. Corporate insiders own 0.49% of the company’s stock.
TMO has been the topic of a number of analyst reports. Jefferies Group LLC reissued a “hold” rating and issued a $195.00 target price on shares of Thermo Fisher Scientific in a report on Thursday. Barclays PLC restated an “overweight” rating and issued a $215.00 price objective (up previously from $200.00) on shares of Thermo Fisher Scientific in a research report on Monday, September 25th. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $197.00 price objective on the stock in a report on Tuesday, August 1st. Goldman Sachs Group, Inc. (The) initiated coverage on Thermo Fisher Scientific in a report on Tuesday, September 26th. They issued a “buy” rating and a $225.00 price target on the stock. Finally, Deutsche Bank AG set a $200.00 price target on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Saturday, June 10th. One research analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Thermo Fisher Scientific currently has a consensus rating of “Buy” and a consensus target price of $202.21.
Shares of Thermo Fisher Scientific Inc (NYSE:TMO) traded up 1.47% on Friday, reaching $189.20. The company’s stock had a trading volume of 1,703,247 shares. Thermo Fisher Scientific Inc has a 52-week low of $139.07 and a 52-week high of $194.30. The stock has a market cap of $73.81 billion, a P/E ratio of 32.96 and a beta of 1.05. The firm’s 50 day moving average is $181.07 and its 200-day moving average is $171.15.
Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The company had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.92 billion. During the same period last year, the company posted $2.03 earnings per share. Thermo Fisher Scientific’s quarterly revenue was up 10.2% on a year-over-year basis. On average, equities research analysts forecast that Thermo Fisher Scientific Inc will post $9.34 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 15th will be issued a dividend of $0.15 per share. The ex-dividend date is Thursday, September 14th. This represents a $0.60 annualized dividend and a dividend yield of 0.32%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 10.45%.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Receive News & Ratings for Thermo Fisher Scientific Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com’s FREE daily email newsletter.